⌘K
Loading ticker…
As of 2026-08-25, Integra LifeSciences Holdings (IART) has a 3-month relative strength percentile of 69 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 57. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.1%, relative volume 0.44×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
IART is held by 27 ETFs as of May 2026. Top owner: FNDA at 0.12% weight, $11M notional. Top 3 carry $21M.
Held by 71 ETFs · $190M across latest filings · largest weight 1.43% (HTEC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| FNDA | 0.12% | $11M | +0.03 pp |
| VTWO | 0.03% | $6M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $5M | — |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.06% | $4M | +0.01 pp |
| VHTVanguard Health Care ETF | 0.02% | $3M | — |
| RWJ | 0.16% | $3M | +0.07 pp |
| VIOVVanguard S&P Small-Cap 600 Value ETF | 0.13% | $2M | +0.03 pp |
| AVSC | 0.06% | $2M | +0.02 pp |
| VFVA | 0.15% | $1M | −0.01 pp |
| ISMD | 0.29% | $923K | +0.12 pp |
Showing 10 of 27 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IART Jan avg: -0.21% median: -2.81% win: 50% σ: 11.54% n: 4 2022-04-12 → 2026-07-31 | IART Feb avg: -4.98% median: -5.50% win: 25% σ: 5.82% n: 4 2022-04-12 → 2026-07-31 | IART Mar avg: -5.80% median: -4.61% win: 25% σ: 8.48% n: 4 2022-04-12 → 2026-07-31 | IART Apr avg: -7.63% median: -3.64% win: 20% σ: 14.46% n: 5 2022-04-12 → 2026-07-31 | IART May avg: 1.27% median: 2.42% win: 60% σ: 32.63% n: 5 2022-04-12 → 2026-07-31 | IART Jun avg: -0.43% median: -3.08% win: 40% σ: 10.53% n: 5 2022-04-12 → 2026-07-31 | IART Jul avg: -0.53% median: 1.87% win: 60% σ: 10.46% n: 5 2022-04-12 → 2026-07-31 | IART Aug avg: -5.66% median: -9.88% win: 25% σ: 14.66% n: 4 2022-04-12 → 2026-07-31 (current) | IART Sep avg: -9.35% median: -10.45% win: 0% σ: 2.74% n: 4 2022-04-12 → 2026-07-31 | IART Oct avg: -0.04% median: -1.30% win: 50% σ: 14.76% n: 4 2022-04-12 → 2026-07-31 | IART Nov avg: 14.64% median: 9.29% win: 100% σ: 10.92% n: 4 2022-04-12 → 2026-07-31 | IART Dec avg: 0.03% median: -1.64% win: 50% σ: 8.49% n: 4 2022-04-12 → 2026-07-31 |